Free Trial

Predictive Oncology (POAI) Institutional Ownership

Predictive Oncology logo
$0.69 -0.03 (-3.82%)
(As of 12/20/2024 05:45 PM ET)

Institutional Ownership Changes (13F Filings) for Predictive Oncology (NASDAQ:POAI)

Current
Institutional Ownership
Percentage
9.04%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$34.08K
Number of
Institutional Sellers
(last 12 months)
0
Get POAI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Predictive Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

POAI Institutional Buying and Selling by Quarter

Predictive Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/2/2024 Carnegie Mellon University10,358$34K0.0%N/A0.255%
10/24/2023Raymond James & Associates118,229$378K0.0%N/A2.934%
8/8/2023 RB Capital Management LLC20,835$101K0.0%-95.0%0.525%
8/1/2023 Carnegie Mellon University10,358$50K0.1%-95.0%0.261%
5/10/2023 RB Capital Management LLC416,693$136K0.0%+161.2%10.496%
2/6/2023Sax Wealth Advisors LLC147,437$45K0.0%+37.2%0.187%
8/11/2022Sax Wealth Advisors LLC107,437$44K0.0%N/A0.162%
7/14/2022 RB Capital Management LLC159,500$65K0.0%N/A0.241%
11/9/2021BlackRock Inc.160,629$214K0.0%+12.9%0.246%
8/17/2021 Price T Rowe Associates Inc. MD106,200$139K0.0%N/A0.162%
8/16/2021 State Street Corp298,632$391K0.0%N/A0.457%
8/13/2021 Geode Capital Management LLC414,705$543K0.0%+198.4%0.635%
8/13/2021 Vanguard Group Inc.1,838,085$2.41M0.0%+231.9%2.813%
8/12/2021 Private Advisor Group LLC26,805$35K0.0%+84.0%0.041%
5/19/2021 Virtu Financial LLC82,810$100K0.0%N/A0.166%
5/17/2021 Armistice Capital LLC2,051,284$2.48M0.1%N/A4.117%
5/17/2021 Goldman Sachs Group Inc.164,258$199K0.0%N/A0.330%
5/13/2021 Renaissance Technologies LLC593,267$718K0.0%N/A1.191%
5/13/2021 Bank of New York Mellon Corp37,348$45K0.0%N/A0.075%
5/12/2021 Northern Trust Corp67,289$81K0.0%+343.4%0.135%
5/12/2021 Geode Capital Management LLC138,973$168K0.0%N/A0.279%
5/11/2021Maryland Capital Management46,000$56K0.0%N/A0.092%
(Data available from 1/1/2016 forward)

POAI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of POAI shares?

During the previous two years, the following institutional investors and hedge funds held shares of Predictive Oncology shares: Raymond James & Associates ($378K), RB Capital Management LLC ($101K), and Sax Wealth Advisors LLC ($45K), Carnegie Mellon University ($34K).Learn more on POAI's institutional investors.

What percentage of Predictive Oncology stock is owned by institutional investors?

9.04% of Predictive Oncology stock is owned by institutional investors. Learn more on POAI's institutional investor holdings.

Which institutional investors have been buying Predictive Oncology stock?

The following institutional investors have purchased Predictive Oncology stock in the last 24 months: RB Capital Management LLC ($257.19K), Raymond James & Associates ($118.23K), Sax Wealth Advisors LLC ($40K), and Carnegie Mellon University ($10.36K).

How much institutional buying is happening at Predictive Oncology?

Institutional investors have bought a total of 425,780 shares in the last 24 months. This purchase volume represents approximately $2.34M in transactions.

Which Predictive Oncology major shareholders have been selling company stock?

The following institutional investors have sold Predictive Oncology stock in the last 24 months: RB Capital Management LLC ($395.86K), and Carnegie Mellon University ($196.79K).

How much institutional selling is happening at Predictive Oncology?

Institutional investors have sold a total of 592,644 shares in the last 24 months. This volume of shares sold represents approximately $2.88M in transactions.



This page (NASDAQ:POAI) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners